Manage your treatment plan, access results, and get dedicated support virtually
Its also vital for mental health
Product Specifications: Purity: 99% based on available third-party documentation
Loading phase protocol (acute injury or initial treatment): Dose: 500 mcg to 1 mg per injection Frequency: Once daily Duration: 7 to 10 days Injection site: Subcutaneous, ideally near the area of concern Timing: Morning or evening, consistency matters more than specific time Maintenance phase protocol: Dose: 500 mcg to 1 mg per injection Frequency: 2 to 3 times per week Duration: 4 to 8 weeks total protocol length Cycle recommendation: 2 months on, 2 months off Unlike traditional BPC-157 acetate, which is often administered twice daily due to its shorter half-life, the enhanced stability of the arginate form typically allows for once-daily dosing during the loading phase
Concentration: community-reported topical serums commonly fall in the ~1-2 mg/mL range (roughly 0.1-0.2%), described for daily scalp application
Nonlinear dendritic integration of sensory and motor input during an active sensing task
